Daniel Lochner | Chief Financial Officer |
Jeffrey Nau | President and Chief Executive Officer |
John Snisarenko | Chief Commercial Officer |
Ken Cacciatore | Cowen |
Joe Catanzaro | Piper Sandler |
Patrick Dolezal | LifeSci Capital |
Chris Neyor | JPMorgan |
Good evening and welcome to Oyster Point Pharma’s Fourth Quarter 2021 Earnings Conference Call. My name is Valerie and I will be your operator today. [Operator Instructions] At this time, I’d like to turn the call over to Mr. Daniel Lochner, Oyster Point Pharma’s Chief Financial Officer. Please go ahead.